ADUS vs NHC
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ADUS · Addus HomeCare$122.50 ▲ 1.18%
NHC · National Healthcare$190.77 ▲ 1.18%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ADUS +5.7%
- NHC +46.5%
Head to head
| Metric | ADUS | NHC |
|---|---|---|
| Price | $122.50 | $190.77 |
| Change today | ▲ 1.18% | ▲ 1.18% |
| Market cap | $2.28B | $2.99B |
| Return, 3 months | +1.4% | -16.2% |
| Return, year to date | +14.1% | +40.6% |
| Return, 1 year | +8.7% | +48.4% |
| P/E (TTM) | 20.4 | 26.4 |
| P/B | 1.9 | 2.7 |
| P/E percentile vs own 5y | 10th | 73rd |
| Dividend yield | – | 1.37% |
| Revenue growth (YoY, latest qtr) | +7.0% | +6.6% |
| Net profit growth (YoY) | +25.1% | -65.4% |
| Gross margin | 32.3% | 39.3% |
| Operating margin | 10.3% | 9.8% |
| Net margin | 7.4% | 7.2% |
| Return on equity | 10.0% | 10.5% |
| Analyst target vs. price | +9.9% | – |
| Analyst buy share | 63% | – |
| RSI (14) | 52 | 30 |
| 30-day volatility | 23.1% | 43.6% |
| Max drawdown, 1 year | -26.8% | -24.0% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | Buy | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- NHC is the largest of the group by market value.
- NHC has returned the most over the past year.
- ADUS carries the lowest trailing P/E.
- ADUS is growing revenue fastest.
- ADUS keeps the most profit per dollar of sales.
- ADUS has been the calmest stock over the last 30 days.